Israel Active

Israel’s NeuraLight uses video from smartphone or web camera, to catch neurological patterns and digital markers. Its computer vision and deep learning algorithms help accelerate development of therapies including Parkinson’s, Alzheimer’s, Multiple Sclerosis, and other neurodegenerative diseases.

Researchers at Israel’s Technion Institute have developed a breakthrough cancer treatment by injecting analgesic nanoparticles into the bloodstream. These anaesthetize the nerves inside the tumors, shutting down communications between them, thus inhibiting tumor growth and spread.

A 102-year-old woman has become the first Israeli to undergo cryoablation (freezing) treatment for breast cancer developed by Israel’s IceCure (see previously). The usual surgical solution was not an option for her, as a previous heart catheterization meant that an operation was too risky.

The NanoGhost cancer treatment targeted delivery mechanism developed by scientists at Israel’s Technion Institute is truly revolutionary (see previously).  It enables the dose of existing immunotherapies (e.g., TRAIL) to be reduced by a millionfold, to prevent toxic side effects.

Israel’s Alike.Health connects patients with a similar medical condition at various stages of treatment or illness, allowing them to learn from each other about ways to cope. The startup has just been selected to join the “Google for Startups Accelerator”, Google’s 3-month mentoring program.  

Israel’s Insurights has developed an AI platform to help employees utilize their health benefits. It answers questions, highlights preventive care benefits, and finds lower-cost providers. Its key feature is Zoe, a “Virtual Chief Health Officer,” who can analyze any insurer’s healthcare plan.

Israel’s Sheba Medical Center is partnering the Liberty Science Center in New Jersey to develop Liberty ARC HealthSpace2030 - a high-tech hospital simulation hub on at Jersey City’s SciTech Scity innovation campus. It will focus on digital health and home healthcare solutions.

Tel Aviv’s Sourasky (Ichilov) Medical Center and Ra’anana’s Sanara Ventures are partnering to turn ideas and projects developed in the neurology department into groundbreaking projects in the fields of digital health and neurology. These include brain diseases, strokes and sleep disorders.

Researchers at Israel’s Technion Institute genetically modified muscle stem cells from diabetic mice to express high levels of GLUT4 molecules, which transport glucose in the body. When re-implanted into the mice, it reduced blood sugar levels by an average of 26% and lowered levels of fatty liver.

Israel’s Triple Jump is developing a unique small insulin pump patch that is placed on the patient’s body. The patch has mobile connectivity capabilities and will be included in a future artificial pancreas system. The device has attracted interest from medical devices giant Medtronic.